Works matching IS 2160763X AND DT 2024 AND VI 13 AND IP 6

Results: 13

Effect of Food, Crushing of Tablets, and Antacid Coadministration on Maribavir Pharmacokinetics in Healthy Adult Participants: Results From 2 Phase 1, Open‐Label, Randomized, Crossover Studies.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 6, p. 644, doi. 10.1002/cpdd.1406

By:

Sun, Kefeng;
Ilic, Katarina;
Xu, Peixin;
Ye, Ran;
Wu, Jingyang;
Song, Ivy H.

Publication type:

Article

Effects of Quinidine or Rifampin Co‐administration on the Single‐Dose Pharmacokinetics and Safety of Rilzabrutinib (PRN1008) in Healthy Participants.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 6, p. 590, doi. 10.1002/cpdd.1404

By:

Rask‐Madsen, Christian;
Katragadda, Suresh;
Li, Mengyao;
Ucpinar, Sibel;
Chinn, Leslie;
Arora, Puneet;
Smith, Patrick

Publication type:

Article

Comparative Pharmacokinetics and Safety Assessment of 1st‐ and 2nd‐Generation Zinpentraxin Alfa Drug Products in Healthy Volunteers: A Randomized Crossover Study.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 6, p. 655, doi. 10.1002/cpdd.1403

By:

Mai, Tu H.;
Yadav, Rajbharan;
Arjomandi, Audrey;
Jung, Christine;
Meier, Monika M.;
Donaldson, Francis;
Zhao, Rui;
Ding, Han‐Ting;
Hsu, Joy C.;
Kamath, Nikhil;
Pan, Lin

Publication type:

Article

Bioequivalence of Elagolix/Estradiol/Norethindrone Acetate Fixed‐Dose Combination Product: Phase 1 Results in Healthy Pre‐ and Postmenopausal Women.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 6, p. 601, doi. 10.1002/cpdd.1399

By:

Chen, Mong‐Jen;
Marroum, Patrick;
Chiu, Yi‐Lin;
Neenan, Melina;
Mostafa, Nael M.;
Shebley, Mohamad

Publication type:

Article

Evaluation of Bioequivalence for Avapritinib Tablets in Chinese Participants Under Fasting Conditions Using a Reference‐Scaled Average Bioequivalence Method.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 6, p. 672, doi. 10.1002/cpdd.1398

By:

Yue, Zenglian;
Wang, Yin;
Li, Zeng;
Jin, Tao;
Sheng, Yucheng

Publication type:

Article

Population Pharmacokinetics and Dosing Simulations for Aripiprazole 2‐Month Ready‐to‐Use Long‐Acting Injectable in Adult Patients With Schizophrenia or Bipolar I Disorder.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 6, p. 631, doi. 10.1002/cpdd.1397

By:

Wang, Yanlin;
Harlin, Matthew;
Larsen, Frank;
Wang, Xiaofeng;
Park, Wansu;
Rich, Benjamin;
Gobburu, Jogarao V.;
Raoufinia, Arash

Publication type:

Article

A Phase 1, Randomized, Double‐Blind, Placebo‐Controlled, Single Ascending Dose Study to Evaluate the Pharmacokinetics, Immunogenicity, Safety, and Tolerability After Subcutaneous Administration of Tozorakimab in Healthy Chinese Participants.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 6, p. 665, doi. 10.1002/cpdd.1391

By:

Li, Yunfei;
Zhang, Hua;
Pandya, Hitesh;
Miao, Liyan;
Reid, Fred;
Jimenez, Eulalia;
Sadiq, Muhammad Waqas;
Moate, Rachel;
Lei, Alejhandra;
Zhou, Xiao‐Hong;
Kell, Chris;
Ding, Junjie;
Zhang, Guanlin;
Zhao, Lina;
Ge, Xiaoyun

Publication type:

Article

Evaluation of the Effects of Meal Type and Acid‐Reducing Agents on the Pharmacokinetics of Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor Agonist.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 6, p. 677, doi. 10.1002/cpdd.1384

By:

Weber, Elijah J.;
Younis, Islam R.;
Wang, Lulu;
Xiao, Deqing;
Barchuk, William T.;
Othman, Ahmed A.

Publication type:

Article

Population Pharmacokinetics of Fasinumab in Healthy Volunteers and Patients With Pain Due to Osteoarthritis of the Knee or Hip.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 6, p. 621, doi. 10.1002/cpdd.1380

By:

Lin, Kuan‐Ju;
Turner, Kenneth C.;
Hassan, Hazem E.;
Harnisch, Lutz O.;
Davis, John D.;
DiCioccio, Albert Thomas

Publication type:

Article

Phase 1 Healthy Volunteer Study of AL01211, an Oral, Non‐brain Penetrant Glucosylceramide Synthase Inhibitor, to Treat Fabry Disease and Type 1 Gaucher Disease.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 6, p. 696, doi. 10.1002/cpdd.1375

By:

Babcock, Michael;
Zheng, Jianhong;
Gail Shurr, Jessica;
Li, Li;
Wang, Bing;
Huertas, Pedro;
Ryan, Philip John;
Shen, Yuqiao;
Garovoy, Marvin

Publication type:

Article

Bioequivalence Between a New Omalizumab Prefilled Syringe With an Autoinjector or with a Needle Safety Device Compared with the Current Prefilled Syringe: A Randomized Controlled Trial in Healthy Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 6, p. 611, doi. 10.1002/cpdd.1373

By:

Sangana, Ramachandra;
Xu, Yan;
Shah, Bharti;
Tian, Xianbin;
Zack, Julia;
Shakeri‐Nejad, Kasra;
Kalluri, Sampath;
Jones, Ieuan;
Ligueros‐Saylan, Monica;
Taylor, Angel Fowler;
Jain, Devendra Kumar;
Scosyrev, Emil;
Uddin, Alkaz;
Laurent, Nathalie;
Paganoni, Paola

Publication type:

Article

Pharmacokinetics of Ubrogepant in Healthy Japanese and White Adults.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 6, p. 688, doi. 10.1002/cpdd.1372

By:

Boinpally, Ramesh;
Trugman, Joel

Publication type:

Article

Issue Information.

Published in:: Clinical Pharmacology in Drug Development, 2024, v. 13, n. 6, p. 585, doi. 10.1002/cpdd.1119
Publication type:: Article